Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.
While the endogenous hallucinogens, N,N-dimethyltryptamine, 5-hydroxy-N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyltryptamine, have been acknowledged as naturally occurring components of the mammalian body for decades, their biological function remains as elusive now as it was at the time of their discovery. The recent discovery of the trace amine associated receptors and the activity of DMT and other hallucinogenic compounds at these receptor sites leads to the hypothesis that the endogenous hallucinogens act as neurotransmitters of a subclass of these trace amine receptors. Additionally, while activity at the serotonin 5-HT2A receptor has been proposed as being responsible for the hallucinogenic affects of administered hallucinogens, in their natural setting the 5-HT2A receptor may not interact with the endogenous hallucinogens at all. Additionally 5-HT2A agonist activity is unable to account for the visual altering effects of many of the administered hallucinogens; these effects may be mediated by one of the endogenous hallucinogen trace amine receptors rather than the serotonin 5-HT2A receptor. Therefore, activity at the trace amine receptors, in addition to serotonin receptors, may play a large role in the sensory altering effects of administered hallucinogens and the trace amine receptors along with their endogenous hallucinogen ligands may serve an endogenous role in mediating sensory perception in the mammalian central nervous system. Thus the theory proposed states that these compounds act as true endogenous hallucinogenic transmitters acting in regions of the central nervous system involved in sensory perception.
Wallach
J V
JV
B.S. Cell and Molecular Biology, Peter Wallach Enterprises, 2758 Furlong Road, Doylestown, PA 18902, United States. jnswallach@gmail.com
D000818:Animals; D018797:Cell Cycle Proteins / Q000502:physiology; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D008024:Ligands; D008322:Mammals; D018377:Neurotransmitter Agents / Q000502:physiology; D009687:Nuclear Proteins / Q000502:physiology; D043562:Receptors, G-Protein-Coupled; D018035:Receptors, Odorant / Q000187:drug effects / Q000502:physiology; D012677:Sensation / Q000187:drug effects / Q000502:physiology*; D014796:Visual Perception / Q000187:drug effects / Q000502:physiology; D000095383:Trace Amine-Associated Receptors
D018797:Cell Cycle Proteins; D006213:Hallucinogens; D008024:Ligands; D018377:Neurotransmitter Agents; D009687:Nuclear Proteins; D043562:Receptors, G-Protein-Coupled; D018035:Receptors, Odorant; C493988:TAAR6 protein, human; D000095383:Trace Amine-Associated Receptors